Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis (ARM-DVT): Methods of a prospective single-arm management study.
Scott C WollerScott M StevensStacy A JohnsonJoseph R BledsoeBrian GalovicJames F LloydEmily L WilsonBrent ArmbrusterR Scott EvansPublished in: Research and practice in thrombosis and haemostasis (2019)
Ninety-day rate of new or recurrent objectively confirmed symptomatic venous thrombosis and VTE-related death. The primary safety outcome is the composite of major and clinically relevant nonmajor bleeding.